📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.75
SENTIMENT
BULLISH
TOTAL VIEWS
18
AEMD Latest News & AI Sentiment Analysis
2 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
Aethlon Medical (Nasdaq: AEMD) Reports Consistent Directional Changes in Second Cohort of Australian Hemopurifier Oncology Trial
Aethlon Medical (AEMD) announced positive interim findings from its Australian oncology feasibility trial, with the second cohort...
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment
Aethlon Medical (AEMD) announced peer-reviewed research identifying elevated mannosylated extracellular vesicles as a biomarker in Long...
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance
A global Ebola outbreak in 2026 has triggered accelerated development across the biotech sector, with specialized players SNGX, AEMD,...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice